• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年患者中持续性非卧床腹膜透析与血液透析选择的死亡风险比较。

Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients.

作者信息

Lunde N M, Port F K, Wolfe R A, Guire K E

机构信息

Department of Medicine, Medical School, University of Michigan, Ann Arbor.

出版信息

Adv Perit Dial. 1991;7:68-72.

PMID:1680460
Abstract

To evaluate patient survival among geriatric patients by dialytic treatment of choice we assigned all patients aged 65 years and older treated in Michigan to either CAPD at home or center hemodialysis (HD) according to the treatment used on day 120 of ESRD therapy. Michigan Kidney Registry files on all 308 CAPD and 1244 HD patients who started ESRD therapy during 1980-1987 were used for this study. The Cox proportional hazards model revealed a significantly increased relative death rate (RR) for patients with diabetes (RR = 1.91, p less than 0.001) and hypertension (RR 1.4, p less than 0.01) as cause of ESRD when adjusting for age, sex, race, treatment and year of incidence. White patients had a 51% higher relative death rate overall when compared to black patients (p less than 0.001) and specifically among hypertensive (RR = 1.65, p less than 0.001) and diabetic patients (RR = 1.59, p less than 0.001). Those differences were still significant when taking higher rates of withdrawal from dialysis among white patients into account. The relative death rates for CAPD patients was essentially the same as for HD patients overall, however, diabetic CAPD patients appeared to have a higher than diabetic HD patients (RR = 1.58, p = 0.1). This statistically not significant difference may be related to selection of patients with cardiovascular risk into CAPD. There was no trend in mortality over time. By modality on day 120, CAPD has similar outcomes as HD in geriatric non diabetic patients.

摘要

为了通过选择的透析治疗方式评估老年患者的生存率,我们根据终末期肾病(ESRD)治疗第120天所采用的治疗方式,将密歇根州所有65岁及以上接受治疗的患者分为家庭持续性非卧床腹膜透析(CAPD)组或中心血液透析(HD)组。本研究使用了密歇根肾脏登记处关于1980 - 1987年间开始ESRD治疗的308例CAPD患者和1244例HD患者的档案。Cox比例风险模型显示,在对年龄、性别、种族、治疗方式和发病年份进行校正后,因糖尿病(相对风险率[RR]=1.91,p<0.001)和高血压(RR = 1.4,p<0.01)导致ESRD的患者相对死亡率显著增加。与黑人患者相比,白人患者总体相对死亡率高51%(p<0.001),在高血压患者(RR = 1.65,p<0.001)和糖尿病患者中尤其如此(RR = 1.59,p<0.001)。考虑到白人患者中较高的透析退出率,这些差异仍然显著。总体而言,CAPD患者的相对死亡率与HD患者基本相同,然而,糖尿病CAPD患者的相对死亡率似乎高于糖尿病HD患者(RR = 1.58,p = 0.1)。这种统计学上不显著的差异可能与选择有心血管风险的患者进行CAPD治疗有关。死亡率没有随时间变化的趋势。在第120天按治疗方式来看,在老年非糖尿病患者中,CAPD与HD的结局相似。

相似文献

1
Comparison of mortality risk by choice of CAPD versus hemodialysis among elderly patients.老年患者中持续性非卧床腹膜透析与血液透析选择的死亡风险比较。
Adv Perit Dial. 1991;7:68-72.
2
Mortality risks of peritoneal dialysis and hemodialysis.腹膜透析和血液透析的死亡风险。
Am J Kidney Dis. 1999 Dec;34(6):1065-74. doi: 10.1016/S0272-6386(99)70012-0.
3
Comparison of survival in CAPD and hemodialysis: a multicenter study.持续性非卧床腹膜透析与血液透析生存率的比较:一项多中心研究。
Adv Perit Dial. 1992;8:136-40.
4
Comparison of long-term survival between hemodialysis and peritoneal dialysis.血液透析与腹膜透析的长期生存率比较。
Adv Perit Dial. 1996;12:79-88.
5
CAPD, an acceptable form of therapy in elderly ESRD patients: a comparative study.持续性非卧床腹膜透析(CAPD)是老年终末期肾病(ESRD)患者可接受的一种治疗方式:一项对比研究。
Adv Perit Dial. 1997;13:158-61.
6
Control of hypertension is better during hemodialysis than during continuous ambulatory peritoneal dialysis in ESRD patients.在终末期肾病(ESRD)患者中,血液透析期间的高血压控制比持续性非卧床腹膜透析期间更好。
Clin Nephrol. 1997 Dec;48(6):341-5.
7
Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes.透析患者与未患糖尿病的非透析终末期肾病患者的胰岛素抵抗情况
J Med Assoc Thai. 2011 Sep;94 Suppl 4:S87-93.
8
Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.基于匹配的治疗剂量对血液透析和腹膜透析的生存情况进行比较。
J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S48-52.
9
Morbidity and mortality of CAPD and hemodialysis.
Kidney Int Suppl. 1993 Feb;40:S4-15.
10
CAPD is a first class treatment: results of an eight-year experience with a comparison of patient and method survival in CAPD and hemodialysis.
Clin Nephrol. 1988;30 Suppl 1:S3-7.

引用本文的文献

1
Shared decision making in elderly patients with kidney failure.老年肾衰竭患者的共同决策
Nephrol Dial Transplant. 2024 Apr 26;39(5):742-751. doi: 10.1093/ndt/gfad211.
2
Decision-Making in Geriatric Patients with End-Stage Renal Disease: Thinking Beyond Nephrology.老年终末期肾病患者的决策:超越肾脏病学的思考
J Clin Med. 2018 Dec 20;8(1):5. doi: 10.3390/jcm8010005.
3
Comparisons of hemodialysis and CAPD in patients over 65 years of age: a meta-analysis.65岁以上患者血液透析与持续性非卧床腹膜透析的比较:一项荟萃分析。
Int Urol Nephrol. 2001;33(2):259-64. doi: 10.1023/a:1015268307680.